SEDANA MEDICAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.76 SEK | -0.67% |
|
-8.32% | -36.27% |
| Feb. 15 | Transcript : Sedana Medical AB, Q4 2023 Earnings Call, Feb 15, 2024 | |
| Feb. 15 | Sedana Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presenter SpeechOscar Bergman (Analysts)We have 3 more presenting companies here at Redeye Med...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company's main shareholders are board members, Linc AB and Magiola Consulting AB.
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
14.76
SEK
Average target price
35.5
SEK
Spread / Average Target
+140.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.27% | 135M | |
| -60.76% | 78.84M |
- Stock Market
- Equities
- SEDANA Stock
- News Sedana Medical AB
- Transcript : Sedana Medical AB - Special Call
